Cleared Traditional

Veuron-Brain-pAb (K203142) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K203142 · Heuron Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
87d
Days
Class 2
Risk

K203142 is an FDA 510(k) clearance for the Veuron-Brain-pAb. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Heuron Co., Ltd. (Incheon, KR). The FDA issued a Cleared decision on January 15, 2021 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Heuron Co., Ltd. devices

Submission Details

510(k) Number K203142 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 2020
Decision Date January 15, 2021
Days to Decision 87 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 107d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Lighten Bridge, LLC
Edward Park

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 787
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K203142.
QUIBIM Precision Prostate (qp-Prostate)
K203582 · Quibim S.L. · Feb 2021
IBM iConnect Access
K203104 · Merge Healthcare Incorporated · Jan 2021
AccuBrain
K202847 · Brainnow Medical Technology Limited · Jan 2021
ViewPoint 6
K203677 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Jan 2021
BrainInsight
K202414 · Hyperfine Research, Inc. · Jan 2021
AI Metrics
K202229 · Ai Metrics, LLC · Dec 2020